These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38661480)

  • 21. QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®.
    Jaffar-Aghaei M; Khanipour F; Maghsoudi A; Sarvestani R; Mohammadian M; Maleki M; Havasi F; Rahmani H; Karagah AH; Kazemali MR
    Eur J Pharm Sci; 2022 Jun; 173():106171. PubMed ID: 35378209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Versatility on demand - The case for semi-solid micro-extrusion in pharmaceutics.
    Rahman J; Quodbach J
    Adv Drug Deliv Rev; 2021 May; 172():104-126. PubMed ID: 33705878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additive manufacturing of personalized orodispersible warfarin films.
    Sjöholm E; Sandler N
    Int J Pharm; 2019 Jun; 564():117-123. PubMed ID: 30974195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding pharmaceutical quality by design.
    Yu LX; Amidon G; Khan MA; Hoag SW; Polli J; Raju GK; Woodcock J
    AAPS J; 2014 Jul; 16(4):771-83. PubMed ID: 24854893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On demand manufacturing of patient-specific liquid capsules via co-ordinated 3D printing and liquid dispensing.
    Okwuosa TC; Soares C; Gollwitzer V; Habashy R; Timmins P; Alhnan MA
    Eur J Pharm Sci; 2018 Jun; 118():134-143. PubMed ID: 29540300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of mechanistic models to identify critical formulation and process variables of pastes for 3D printing of modified release tablets.
    Zidan A; Alayoubi A; Asfari S; Coburn J; Ghammraoui B; Aqueel S; Cruz CN; Ashraf M
    Int J Pharm; 2019 Jan; 555():109-123. PubMed ID: 30453019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advancing Mass Spectrometry Technology in cGMP Environments.
    Ren D
    Trends Biotechnol; 2020 Oct; 38(10):1051-1053. PubMed ID: 32718778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-dimensional drug printing: a structured review.
    Ursan ID; Chiu L; Pierce A
    J Am Pharm Assoc (2003); 2013; 53(2):136-44. PubMed ID: 23571620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Snapshot of Current Updates and Future Prospects of 3D Printing in Medical and Pharmaceutical Science.
    Agrawal R; Garg A; Deshmukh R
    Curr Pharm Des; 2023; 29(8):604-619. PubMed ID: 36852810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceutical Product Development Exploiting 3D Printing Technology: Conventional to Novel Drug Delivery System.
    Alam MS; Akhtar A; Ahsan I; Shafiq-Un-Nabi S
    Curr Pharm Des; 2018; 24(42):5029-5038. PubMed ID: 30727872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dropwise additive manufacturing of pharmaceutical products for melt-based dosage forms.
    Içten E; Giridhar A; Taylor LS; Nagy ZK; Reklaitis GV
    J Pharm Sci; 2015 May; 104(5):1641-9. PubMed ID: 25639605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Additive Manufacturing of Solid Products for Oral Drug Delivery Using Binder Jetting Three-Dimensional Printing.
    Wang Y; Müllertz A; Rantanen J
    AAPS PharmSciTech; 2022 Jul; 23(6):196. PubMed ID: 35835970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inkjet Printing of Pharmaceuticals.
    Carou-Senra P; Rodríguez-Pombo L; Awad A; Basit AW; Alvarez-Lorenzo C; Goyanes A
    Adv Mater; 2024 Mar; 36(11):e2309164. PubMed ID: 37946604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing.
    Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Rome S; Schubert MA; Aerts L; De Beer T
    Eur J Pharm Biopharm; 2018 Jun; 127():92-103. PubMed ID: 29452241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3D printing: Innovative solutions for patients and pharmaceutical industry.
    Tracy T; Wu L; Liu X; Cheng S; Li X
    Int J Pharm; 2023 Jan; 631():122480. PubMed ID: 36509225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. System-wide hybrid MPC-PID control of a continuous pharmaceutical tablet manufacturing process via direct compaction.
    Singh R; Ierapetritou M; Ramachandran R
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1164-82. PubMed ID: 23523542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel 3D Printed Modular Tablets Containing Multiple Anti-Viral Drugs: a Case of High Precision Drop-on-Demand Drug Deposition.
    Lu A; Zhang J; Jiang J; Zhang Y; Giri BR; Kulkarni VR; Aghda NH; Wang J; Maniruzzaman M
    Pharm Res; 2022 Nov; 39(11):2905-2918. PubMed ID: 36109460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlling drug release with additive manufacturing-based solutions.
    Patel SK; Khoder M; Peak M; Alhnan MA
    Adv Drug Deliv Rev; 2021 Jul; 174():369-386. PubMed ID: 33895213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A quality by design study applied to an industrial pharmaceutical fluid bed granulation.
    Lourenço V; Lochmann D; Reich G; Menezes JC; Herdling T; Schewitz J
    Eur J Pharm Biopharm; 2012 Jun; 81(2):438-47. PubMed ID: 22446063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.